Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ML0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,648
Award facts
- Contract value 100% obligated
- $47,647.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $47,647.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. The award was issued on January 29, 2026, with an ultimate completion date of January 30, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions, and this procurement supports the Defense Health Agency's pharmaceutical supply requirements for military treatment facilities and related defense healthcare programs.
This delivery order operates under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 31, 2031). The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and its federal contract portfolio demonstrates extensive capability in fulfilling diverse medical supply needs for defense and federal civilian agencies through competitively awarded delivery orders with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DR26F0ML0?
SPE2DR26F0ML0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F0ML0 worth?
The government has obligated $47,648 on SPE2DR26F0ML0.
Is contract SPE2DR26F0ML0 an order under another contract?
Yes. SPE2DR26F0ML0 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0ML0 competed?
The extent of competition for SPE2DR26F0ML0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award